Filana Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-11.9M | $-14.9M | $-14.1M | $-12.4M | $31.5M | $-3.4M | $-2.6M | $-12.0M |
| Depreciation & Amortization | $68.0K | $58.0K | $45.0K | $15.0K | — | $122.0K | $163.0K | $232.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $3.0M | $4.3M | $3.5M | $3.8M | $3.1M | $6.6M | $5.4M | $20.1M |
| Net Cash from Operating Activities | $-8.2M | $-12.2M | $-9.1M | $-9.5M | $-6.9M | $-7.2M | $-260.0K | $-143.0K |
| Investing Activities | ||||||||
| Capital Expenditures | — | $75.0K | $195.0K | $80.0K | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $2.1M | $-2.2M | — | — | — | $17.6M | $59.9M | $52.5M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $-284.0K | — | — | — | $-34.2M | $8.7M | $-83.3M |
| Net Change in Cash | $-6.1M | $-14.7M | $-9.3M | $-8.0M | $-767.0K | $-23.8M | $68.3M | $-31.0M |
| Free Cash Flow | — | $-12.3M | $-9.2M | $-9.6M | — | — | — | — |